Connor Clark & Lunn Investment Management Ltd. Purchases Shares of 23,116 Intuitive Surgical, Inc. (NASDAQ:ISRG)

Connor Clark & Lunn Investment Management Ltd. acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 23,116 shares of the medical equipment provider’s stock, valued at approximately $11,356,000.

Several other hedge funds and other institutional investors have also recently modified their holdings of ISRG. Hazlett Burt & Watson Inc. lifted its holdings in Intuitive Surgical by 5.8% in the 3rd quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock worth $177,000 after buying an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. boosted its holdings in Intuitive Surgical by 4.1% in the third quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after acquiring an additional 20 shares in the last quarter. Ullmann Wealth Partners Group LLC raised its holdings in Intuitive Surgical by 1.6% in the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock worth $653,000 after purchasing an additional 21 shares in the last quarter. Meeder Advisory Services Inc. lifted its position in shares of Intuitive Surgical by 0.3% in the 3rd quarter. Meeder Advisory Services Inc. now owns 7,386 shares of the medical equipment provider’s stock worth $3,629,000 after purchasing an additional 22 shares during the period. Finally, One Wealth Management Investment & Advisory Services LLC boosted its stake in shares of Intuitive Surgical by 3.4% during the 2nd quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock valued at $310,000 after purchasing an additional 23 shares in the last quarter. 83.64% of the stock is owned by institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 26.54 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the business’s stock in a transaction on Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,597,425. The trade was a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 50,935 shares of company stock worth $26,305,169. 0.90% of the stock is owned by insiders.

Intuitive Surgical Stock Up 1.6 %

Shares of ISRG stock opened at $550.43 on Friday. The company has a 50 day moving average price of $503.57 and a 200-day moving average price of $461.88. Intuitive Surgical, Inc. has a 52 week low of $304.50 and a 52 week high of $551.78. The firm has a market capitalization of $196.05 billion, a PE ratio of 88.49, a P/E/G ratio of 5.30 and a beta of 1.39.

Intuitive Surgical (NASDAQ:ISRG) last announced its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analyst Ratings Changes

Several analysts have commented on the stock. Raymond James raised their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an “outperform” rating in a report on Monday, October 14th. Stifel Nicolaus increased their price objective on Intuitive Surgical from $475.00 to $525.00 and gave the stock a “buy” rating in a report on Friday, October 18th. Robert W. Baird boosted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Citigroup increased their price target on shares of Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have assigned a buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $524.61.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.